These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39221208)
1. Engineered cyanobacteria-Fe Li Y; Fan Y; Gao J; Zheng S; Xing Y; He C; Ye S; Xia H; Wang G; Pan H; Xia W; Sui M; Wang H; Liu J; Xie M; Xu K; Zhang Y Mater Today Bio; 2024 Oct; 28():101192. PubMed ID: 39221208 [TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy. Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974 [TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of Fe Zhang Y; Liu S; Li D; He C; Wang D; Wei M; Zheng S; Li J Colloids Surf B Biointerfaces; 2023 Sep; 229():113452. PubMed ID: 37474429 [TBL] [Abstract][Full Text] [Related]
4. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer. Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876 [TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579 [No Abstract] [Full Text] [Related]
8. M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy. Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM Mol Pharm; 2023 Nov; 20(11):5921-5936. PubMed ID: 37874541 [TBL] [Abstract][Full Text] [Related]
9. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles. Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987 [TBL] [Abstract][Full Text] [Related]
10. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer. Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235 [TBL] [Abstract][Full Text] [Related]
11. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473 [TBL] [Abstract][Full Text] [Related]
12. Bio-Responsive nanoparticle for tumor targeting and enhanced photo-immunotherapy. Tian D; Qin F; Zhao H; Zhang C; Wang H; Liu N; Ai Y Colloids Surf B Biointerfaces; 2021 Jun; 202():111681. PubMed ID: 33714187 [TBL] [Abstract][Full Text] [Related]
13. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy. Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398 [TBL] [Abstract][Full Text] [Related]
14. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy. Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636 [TBL] [Abstract][Full Text] [Related]
16. Selective targeting of tumor associated macrophages in different tumor models. Kakoschky B; Pleli T; Schmithals C; Zeuzem S; Brüne B; Vogl TJ; Korf HW; Weigert A; Piiper A PLoS One; 2018; 13(2):e0193015. PubMed ID: 29447241 [TBL] [Abstract][Full Text] [Related]
17. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy. Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627 [TBL] [Abstract][Full Text] [Related]
18. Enhanced Cellular Ablation by Attenuating Hypoxia Status and Reprogramming Tumor-Associated Macrophages via NIR Light-Responsive Upconversion Nanocrystals. Ai X; Hu M; Wang Z; Lyu L; Zhang W; Li J; Yang H; Lin J; Xing B Bioconjug Chem; 2018 Apr; 29(4):928-938. PubMed ID: 29466856 [TBL] [Abstract][Full Text] [Related]
19. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy. Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762 [TBL] [Abstract][Full Text] [Related]
20. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]